These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 30473423)
21. IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis. Le Moigne V; Roux AL; Mahoudo H; Christien G; Ferroni A; Dumitrescu O; Lina G; Bouchara JP; Plésiat P; Gaillard JL; Canaan S; Héry-Arnaud G; Herrmann JL Microbiol Spectr; 2022 Jun; 10(3):e0019222. PubMed ID: 35583329 [TBL] [Abstract][Full Text] [Related]
22. Investigating transmission of Mycobacterium abscessus amongst children in an Australian cystic fibrosis centre. Yan J; Kevat A; Martinez E; Teese N; Johnson K; Ranganathan S; Harrison J; Massie J; Daley A J Cyst Fibros; 2020 Mar; 19(2):219-224. PubMed ID: 30853372 [TBL] [Abstract][Full Text] [Related]
23. Nontuberculous mycobacteria in cystic fibrosis patients on the Island of Gran Canaria. A population study. Campos-Herrero MI; Chamizo FJ; Caminero JA; Gilarranz R; Cabrera G; Cuyás J J Infect Chemother; 2016 Aug; 22(8):526-31. PubMed ID: 27262751 [TBL] [Abstract][Full Text] [Related]
24. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Mussaffi H; Rivlin J; Shalit I; Ephros M; Blau H Eur Respir J; 2005 Feb; 25(2):324-8. PubMed ID: 15684298 [TBL] [Abstract][Full Text] [Related]
25. Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis. Gramegna A; Misuraca S; Lombardi A; Premuda C; Barone I; Ori M; Amati F; Retucci M; Nazzari E; Alicandro G; Ferrarese M; Codecasa L; Bandera A; Aliberti S; Daccò V; Blasi F Respir Res; 2023 Dec; 24(1):316. PubMed ID: 38104098 [TBL] [Abstract][Full Text] [Related]
26. Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population. Qvist T; Pressler T; Thomsen VO; Skov M; Iversen M; Katzenstein TL Transplant Proc; 2013; 45(1):342-5. PubMed ID: 23267788 [TBL] [Abstract][Full Text] [Related]
27. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Floto RA; Olivier KN; Saiman L; Daley CL; Herrmann JL; Nick JA; Noone PG; Bilton D; Corris P; Gibson RL; Hempstead SE; Koetz K; Sabadosa KA; Sermet-Gaudelus I; Smyth AR; van Ingen J; Wallace RJ; Winthrop KL; Marshall BC; Haworth CS; Thorax; 2016 Jan; 71 Suppl 1(Suppl 1):i1-22. PubMed ID: 26666259 [TBL] [Abstract][Full Text] [Related]
28. Nontuberculous mycobacteria in patients with cystic fibrosis. Leung JM; Olivier KN Semin Respir Crit Care Med; 2013 Feb; 34(1):124-34. PubMed ID: 23460012 [TBL] [Abstract][Full Text] [Related]
29. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases]. Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567 [TBL] [Abstract][Full Text] [Related]
30. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis. Burke A; Smith D; Coulter C; Bell SC; Thomson R; Roberts JA Clin Pharmacokinet; 2021 Sep; 60(9):1081-1102. PubMed ID: 33982266 [TBL] [Abstract][Full Text] [Related]
31. [Nontuberculous mycobacteria in cystic fibrosis]. Le Bourgeois M; Sermet-Gaudelus I; Catherinot E; Gaillard JL Arch Pediatr; 2005 Aug; 12 Suppl 2():S117-21. PubMed ID: 16129322 [TBL] [Abstract][Full Text] [Related]
32. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR; Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668 [TBL] [Abstract][Full Text] [Related]